opens in a new window
Latest News & Media From Quay Pharma
April 08 2022
SGS Quay’s Microbiome Expertise Ideal For New IBD Drug Development Project
SGS Quay Pharma is partnering on a major project to develop and commercialise an inflammatory...
Read MoreFebruary 10 2021
Quay Lends its Expertise to Medicines Discovery Catapult Network
Leading pharmaceutical outsourcing specialist Quay Pharma has become the first CDMO (contract development…
Read MoreDecember 09 2020
Quay Expands in US with Greater Boston Facility
Quay Expands with US Development and Manufacturing Facility. Following the opening of its office in Boston earlier this year, UK based CDMO Quay Pharma…
Read MoreNovember 23 2020
Quay Receives Funding For Covid-19 Treatment Project
Quay Pharma has been awarded Innovate Funding from the Welsh Government for a significant anti-viricidal project as part of...
Read MoreOctober 31 2020
Quay Expands with Second UK Facility
Quay Pharma is further expanding its operations with the purchase of a second UK laboratory and office facility. Located at Newtech Square…
Read MoreSeptember 15 2020
Partnership Accelerates Drug Development
We are strengthening our range of pre-clinical services with the establishment of a new partnership with XenoGesis, the UK’s largest independent...
Read MoreAugust 11 2020
Quay Pharmaceuticals Expands in America
Quay Pharma has underlined its position as a major player in the global pharmaceutical contract development and manufacturing (CDMO) sector with the creation...
Read MoreJuly 08 2020
New Drug for TACTIC-E COVID-19 Trial
Pharmaceutical outsourcing specialist Quay Pharma’s acknowledged expertise in microbial biotherapeutics has played a crucial role...
Read MoreMay 22 2020
Knowledge Transfer Partnership (KTP)
Quay Pharma (Deeside, UK) and Liverpool John Moores University (LJMU – Liverpool, UK) are delighted to announce that their Knowledge Transfer...
Read More
INSPECTED FACILITIES
